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Background: Bacopa monnieri Linn. (Plantaginaceae), a well-known medicinal plant, is widely used in traditional
medicine system. It has long been used in gastrointestinal discomfort, skin diseases, epilepsy and analgesia. This
research investigated the in vitro antimicrobial activity of Bacopa monnieri leaf extract against Staphylococcus aureus
and the interaction of possible compounds involved in this antimicrobial action.
Methods: Non-edible plant parts were extracted with ethanol and evaporated in vacuo to obtain the crude extract.
A zone of inhibition studies and the minimum inhibitory concentration (MIC) of plant extracts were evaluated
against clinical isolates by the microbroth dilution method. Docking study was performed to analyze and identify
the interactions of possible antimicrobial compounds of Bacopa monnieri in the active site of penicillin binding
protein and DNA gyrase through GOLD 4.12 software.
Results: A zone of inhibition studies showed significant (p < 0.05) inhibition capacity of different concentrations of
Bacopa monnieri’s extract against Staphylococcus aureus. The extract also displayed very remarkable minimum
inhibitory concentrations (≥16 μg/ml) which was significant compared to that (≥75 μg/ml) of the reference
antibiotic against the experimental strain Staphylococcus aureus. Docking studies recommended that luteolin, an
existing phytochemical of Bacopa monnieri, has the highest fitness score and more specificity towards the DNA
gyrase binding site rather than penicillin binding protein.
Conclusions: Bacopa monnieri extract and its compound luteolin have a significant antimicrobial activity against
Staphylococcus aureus. Molecular binding interaction of an in silico data demonstrated that luteolin has more
specificity towards the DNA gyrase binding site and could be a potent antimicrobial compound.
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Effective therapeutic options to combat Staphylococcus
aureus infection are still limited. And this makes a major
burden to control Staphylococcus aureus [1]. S. aureus is
a commensal Gram-positive bacterium, which colonizes
in human nasal mucosa either permanently or tran-
siently [2], causing severe infections eventually [3,4]. But
the clinical symptoms are not visualized until the immune
system is affected [5]. However, the major problem in
controlling the S. aureus infection is the occurrence of
multi-drug resistance produced mainly due to the misuse
of antibiotics. This is also caused by the treatment of non-
bacterial infections with antibiotics or inadequate compli-
ance with the regulations for drug ingestion. Therefore,
new therapeutic molecule is an urgence to be introduced
as antibiotic in the treatment of multi-drug resistant
S. aureus. Several studies have proposed that phytocom-
pounds are the best alternative to develop therapies for
multidrug resistant bacterial infections [6-8].
Bacopa monnieri (L.) Wellst. (Family: Plantaginaceae)
is known as Herpestis monniera. It is a water hyssop or
“Brahmi” and is reputed as Ayurvedic medicine. It is
used for gastrointestinal discomfort, rejuvenation, pro-
moting memory and intellect, skin disorders, epilepsy,
pyrexia and analgesia [9]. Number of biologically active
compounds has been isolated from this plant. GC-MS
analysis of the leaf extract of this plant showed the pres-
ence of tetracyclic triterpenoids, saponin, bacosides A
and B phytosterols, hersaponin, D-mannitol, flavonoids
viz., luteolin-7-glucoside, apigenin-7-glucocronide, alka-
loids such as nicotine and herpestine, betulic acid,
β-sitosterol, stigma-sterol and its esters, aspartic acid,
glutamic acid and serine [10]. Despite enormous possi-
bilities of this plant, no compound-activity relationship
study has been conducted yet to investigate the phyto-
chemicals responsible for its antimicrobial action. This
research evaluates the in vitro antimicrobial activity of
B. monnieri against S. aureus establishing the inter-
action of existing phytocompounds involved in this




Mueller-Hinton broth and agar media (Hi media, India;
final pH 7.3 ± 0.2 at 25°C), was used for the deter-
mination of MIC and antibacterial activity. Tetracycline
(50 μg/disk) and ampicillin disks (50 μg/disk) were pro-
cured from Oxoid, England.
Collection and identification of plant materials
The plant B. monnieri was selected by Talha Bin Emran,
Lecturer, Department of Pharmacy, BGC Trust University
Bangladesh. Fresh leaves of B. monnieri were collectedfrom the Chittagong University hilly forest on December
2013. The plant was identified by Dr. Shaikh Bokhtear
Uddin, Taxonomist and Associate Professor, Department
of Botany, University of Chittagong-4331, Bangladesh. A
voucher specimen (Accession Number: 36285) containing
the identification characteristics of the plant has been pre-
served in the Bangladesh National Herbarium for future
reference.
Preparation of crude ethanol extract
The fresh leaves of B. monnieri were washed imme-
diately after collection and chopped into small pieces, air
dried and ground (Moulinex Blender AK-241, Moulinex,
France) into powder (40-80 mesh, 500 g). The resulting
powder was soaked in an Erlenmeyer flask of absolute
ethanol (2.0 L, at room temperature) and left for seven
days allowing occasional stirring of the flask. Filtrate
obtained through cheesecloth and Whatman filter paper
No. 1 was concentrated under reduced pressure at the
temperature below 50°C using a rotatory evaporator
(RE 200, Bibby Sterling Ltd., UK). The extracts (yield
4.4 - 5.6% w/w) were all placed in glass Petri dishes
(90 × 15 mm, Pyrex, Germany) to allow an air-dry for
complete evaporation of solvent.
Study of antibacterial activity
Bacterial strain
Gram-positive Staphylococcus aureus (ATCC6538) was
used for screening the antibacterial effect of the plant ex-
tract. Bacterial strain was collected from the Microbiology
Division of Bangladesh Council of Scientific and Industrial
Research (BCSIR), Chittagong-4220, Bangladesh.
Preparation of sample solutions
Small amount (1, 2 and 3 mg) of solid sample was dis-
solved in a definite volume (1 ml) of DMSO to make a so-
lution of 1 mg/ml. DMSO was chosen as solvent because
it does not have any inhibitory effect on bacterial cultures
and it has extraordinary capacity to dissolve solid sample
completely.
Media preparation
The bacterial strain was grown and maintained on Standard
Nutrient Agar (DIFCO) media (Hi media, India) at 37°C
and pH 7.3 ± 0.2. The bacterium was sub-cultured over-
night in nutrient agar broth which was further adjusted to
obtain turbidity comparable to McFarland (0.5) standard
when required. Test tube slants of nutrient agar medium
were prepared for the maintenance of culture. Then a
small amount of the collected microorganism was trans-
ferred to the test tubes with the help of sterilized needles.
A number of test tubes were freshly cleaned for bacterial
pathogen. The inoculated slants were inoculated at
temperature below laboratory condition.
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The antibacterial activity of the extract was determined
by disk diffusion technique (National Committee for
Clinical Laboratory Standards, NCCLS, 2002). The test
microbes were taken from the broth culture with inocu-
lating loop and transferred to test tubes containing
5.0 ml sterile distilled water. The inoculums were added
until the turbidity was equal to 0.5 McFarland standards.
Cotton swab was then used to inoculate the test tube
suspension onto the surface of the Muller Hinton agar
plate and the uniformly swabbed plates were then
allowed to dry. On the dry inoculated surfaces prepared
paper disks were placed as follows. Sterilized Whatman
paper disks (6 mm in diameter) were prepared previ-
ously by punching the filter paper with the help of a
punch machine. After that the disks were placed upon
0.5 ml of the desired solution (1, 2 and 3 mg/disk) of the
extract. After each application the disks were allowed to
the temperature 40°C (one minute) for drying purposes.
The disks containing plant extract were placed with
blunt-nosed thumb forceps on the inoculated plates at
equidistance in a circle. These plates were kept for 4-6 h
at a low temperature (<8°C) to allow for diffusion of the
extract from the disk into the medium. The same was
done for negative control (ethanol). The plates were in-
cubated at 37°C for 24 h. The experiment was conducted
in triplicates. Antimicrobial activity was determined by a
measurement of the inhibition zone diameter (mm)
around each test organism.
Minimum inhibitory concentration (MIC) determination
Minimum inhibitory concentration was determined by
the microdilution method using serially diluted (2 folds)
plant extract according to the National Committee for
Clinical Laboratory Standards (NCCLS) (National Com-
mittee for Clinical Laboratory Standards, 2000). The
MIC of the extract was determined by the dilution of
B. monnieri extract with the concentrations of 0.0-25,
0.0-50, 0.0-75, 0.0-100, 0.0-125, and 0.0-150 μg/ml.
Equal volume of each extract and nutrient broth was
mixed in a test tube. Specifically 0.1 ml of standardized
inoculum (1-2 × 107 cfu/ml) was added in each tube.
The tubes were incubated aerobically at 37°C for 18-
24 h. Two control tubes were maintained for each test
batch. These included antibiotic control (a tube contai-
ning extract and growth media without inoculum) and
organism control (a tube containing the growth medium,
saline and the inoculum). The lowest concentration
(highest dilution) of the extract that produced no visible
bacterial growth (no turbidity) was considered as MIC.
Statistical analysis
All data are presented as mean ± standard deviation
(SD). The data were analyzed by a statistical softwarestatistical package for social science (SPSS, version 18.0,
IBM Corporation, NY, USA) using Tukey’s multiple
range post hoc tests. The values were considered signifi-
cantly different at p < 0.05.
Docking approach
To have a better understanding about the inhibitory
mechanism as well as the mode of interactions of the
phytochemical compounds of the crude extract, docking
analysis was accomplished using the GOLD 4.12 pack-
age. Two primary drug-target-pathways, i.e., penicillin-
binding protein [13] and DNA gyrase [14] of S. aureus
were subject to forecast the mechanism of plant derived
compounds. Protein X-ray structure pdb ID: 3vsl and
3g7b was retrieved from protein data bank [15] and
compared with standard inhibitor orientation in crystal
structure. From the literature review, all compounds
represented in Figure 1 were drawn in Symyx Draw 4.0
and to prepare for docking using the Sybyl 7.3 Molecular
Modeling Suite of Tripos, Inc. Three dimensional (3D)
conformations generated by using Concord 4.0 [16];
hydrogen atoms were added and charges were loaded
using the Gasteiger and Marsili charge calculation
method [17]. Basic amines were protonated and acidic
carboxyl groups were de-protonated prior to charge cal-
culation. The ligands were minimized with the Tripos
Force Field prior to docking using the Powell method
with an initial Simplex [18] optimization and 1000 inter-
actions or gradient termination at 0.01 kcal/(mol*A).
The input ligand file format was mol2 for all docking
programs investigated. Three dimensional structure of
standard drugs i.e., penicillin G and ciprofloxacin was
occupied from zinc databases. The docking tool “GOLD”
utilizes genetic algorithm to explore the rotational flexi-
bility of receptor hydrogen’s and ligand conformational
flexibility [19]. Such GOLD docking was carried out
using the wizard with default parameters population size
(100); selection pressure (1.1); number of operations
(10,0 00); number of islands (1); niche size (2); and oper-
ator weights for migrate (0), mutate (100), and crossover
(100). The active site with a 10 Å radius sphere was de-
fined by selecting an active site residue of protein. De-
fault genetic algorithm settings were used for all
calculations and a set of 10 solutions was saved for each
ligand. GOLD was used by a GoldScore fitness function.
GoldScore is a molecular mechanism like function and
has been optimized for the calculation of binding posi-
tions of ligand. It takes into account for four terms:
Fitness ¼ S hb extð Þ þ 1:3750S vdw extð Þ þ S hb intð Þ
þ 1:0000S intð Þ
S intð Þ ¼ S vdw intð Þ þ S torsð Þ
Where, S hb_ext is the protein-ligand hydrogen bonding
Figure 1 2D structure of all compounds of B. monnieri.
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protein and ligand. S hb_int are the intramolecular hydro-
phobic interactions whereas S vdw_ int is the contribution
due to intramolecular strain in the ligand.
Results
In vitro antimicrobial assay
Results for the antibacterial activity of B. monnieri extract
showed that the mean zone of inhibition (13.0-15.0 mm)
produced by the extract was close to those produced by
the reference antibiotics, i.e., tetracycline and ampicillin
which had the zone of inhibitions between 16 to 20 mm.
The extract of three different concentrations (1, 2 and
3 mg/disk) produced significant (p < 0.05) zone of inhi-
bition against S. aureus and the values were 13.33 ± 2.08,
13.33 ± 2.08 and 15.33 ± 1.52 for 1, 2 and 3 mg/disk, re-
spectively. The result of antibacterial activity of B. mon-
nieri ethanol extract is shown in Table 1.
Minimum inhibitory concentration
The minimum inhibitory concentrations of B. monnieri
leaf extract for different bacterial strains were rangedfrom 25 to 100 μl/ml (Table 2). The arbitrary MIC
against the Gram-positive bacteria S. aureus was greater
than or equal to 75 for the extract and 16 for the refe-
rence antibiotic tetracycline.
Docking experiments
Considering the results obtained in in vitro study, it was
thought worthy to perform molecular docking studies
which correlate both in silico and in vitro results. Docking
studies are used at different stages of drug discovery such
as to predict a ligand-receptor interaction and also to rank
the compounds based on the binding energies or fitness
score [20]. In our present study, docking of tested com-
pounds with the primary drug pathway for S. aureus was
performed, and the corresponding fitness score was also
determined as shown in Table 3. The interacting energies
followed the order of the best fitness core. Highest fitness
scored compound was further subjected to compare its
binding pattern and molecular interaction with the stand-
ard drug penicillin G and ciprofloxacin.
In the docking studies of DNA gyrase binding site,
luteolin among the other tested compounds has the
Table 1 in vitro antibacterial activity of B. monnieri ethanol extract
Bacterial
type
Test organism Source ID
(ATCC)
Diameter of zone of inhibition (mm)
Bacopa monnieri Standard antibiotics
Gram + ve 1 mg/disk 2 mg/disk 3 mg/disk Tetracycline (50 μg/disk) Ampicillin (50 μg/disk)
Staphylococcus aureus 6538 13.33 ± 2.08a 13.33 ± 2.08b 15.33 ± 1.52c 16.00 ± 3.54d 20.00 ± 1.60e
Data are shown as mean ± SD for triplicate of concentration. Different superscript letters (a-e) shown in the data indicate that the values are significantly different
(Tukey’s multiple range, post hoc test, p < 0.05) from each other.
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fitness score 46.48 of ciprofloxacin. Molecular binding
pattern of ciprofloxacin revealed that it has two hy-
drogen bonds with ARG144 and GLY85 consisting of
hydrogen bonding distances 2.634 Å and 2.476 Å shown
in Figure 2. These two hydrogen bonding residues in
luteolin are found to be similar with different hydrogen
bonds viz. 2.641 Å for ARG144 and 2.520 Å for GLY85.
Additionally, it also formed two other hydrogen bonds
with ARG84 and ASP81 having a bonding distance of
2.932 Å and 2.956 Å.
For the most potent inhibitor of penicillin binding pro-
tein, luteolin showed the highest fitness score among the
other tested compounds viz., 45.35 fitness score compared
to its reference standard drug penicillin G 46.48. In con-
text of different binding patterns, luteolin has formed the
three hydrogen bonds SER429, THR621 and THR619
where bonding distances were 3.020, 2.798 and 2.331. On
the other hand, reference drug penicillin G formed hydro-
gen bonds with ASN450, SER778, THR621 and GLN524
with corresponding hydrogen bonds 2.956 Å, 2.968 Å,
2.556 Å and 3.031 Å, respectively. Binding mode and re-
lated interactions are summarized in Figure 3.
The emergence of bacterial resistance to current cli-
nical drugs has brought intention to develop novel anti-
microbial agents for selectively inhibiting the constantly
evolved bacterial targets which have been also conti-
nually promoted with challenges. Presently known target
of Staphyloccus sp. includes PBP (penicillin binding pro-
tein) of peptidoglycan biosynthesis pathway where beta-
lactam antibiotics were known to be effective against it
[21]. A different prescribing drug i.e. Fluroquinolone,
DNA Gyrase A enzyme which is essential for the replica-
tion and super-coiling of DNA, is the main target at this
case. But according to Stephen et al., a highly significant
association between Levofloxacin and CiprofloxacinTable 2 Minimum inhibitory concentrations (MIC) of
B. monnieri and tetracycline against Staphylococcus aureus




Staphylococcus aureus ≥75 ≥16treatment and consequent isolation of MRSA is reported
[22]. However, in this research, molecular docking
analysis suggested that luteolin has the more specificity
towards the DNA gyrase binding site than penicillin
binding protein. Regarding the obtained results, luteolin
could serve as an appropriate starting point for desig-
ning new chemical entities as potent S. aureus inhibitor.
Discussion
Plants have long been a very important source of drug
and many plants have been screened whether they con-
tain compounds with therapeutic activity. Therefore, it is
vital to evaluate the antimicrobial activity of B. monnieri.
The bacterial strain was chosen to be studied as it is an
important pathogen and rapidly develop antibiotic resis-
tance with its increased uses. In disk diffusion technique,
the mean zone of inhibition produced by the commer-
cial antibiotic, tetracycline and ampicillin, was larger
than that produced by ethanol extract. It may be attri-
buted to the fact that the plant extract being in crude
form contains a smaller concentration of bioactive com-
pounds. In classifying the antimicrobial activity it would
be generally expected that a greater number would be
active against Gram-positive than Gram-negative bac-
teria. Apart from this, the higher MIC value is an indica-
tion that either the plant extracts are less effective on
bacteria or the organism has the potential to develop
antibiotic resistance. On the contrary, the low MIC value
for bacteria is an indication of the higher efficacy of the
plant extracts.
Most of the pathogenic bacteria have developed re-
sistance to currently available antibiotics due to their
misuse or overuse. This situation has led to an urgent
need to explore different sources of efficient, less toxic
and cost-effective antimicrobial agents [23,24]. Medicinal
plants play a major role and constitute the backbone of
traditional medicine. According to the World Health
Organization (WHO) estimate, 80% of populations in
developing countries rely exclusively on traditional me-
dicine for their healthcare need. Moreover, 20% of the
available allopathic drugs have an active principal ob-
tained from higher plants [25]. Recognizing the signifi-
cance of indigenous medicinal plants WHO states in its
1997 guideline that locally available effective plants may
Table 3 Gold fitness score of B. monnieri’s all compounds against DNA gyrase and penicillin binding protein
DNA gyrase Penicillin binding protein
Compound name Fitness score S(hb_ext) S(vdw_ext) S(hb_int) S(int) Fitness Score S(hb_ext) S(vdw_ext) S(hb_int) S(int)
Apigenin 46.59 5.57 36.00 0.00 -8.48 41.73 7.29 30.70 0.00 -7.77
Rosavin 51.58 5.44 42.31 0.00 -12.03 41.96 8.88 31.27 0.00 -9.92
Quercetin 45.71 6.04 37.32 0.00 -11.64 40.14 9.37 30.55 0.00 -11.23
Feruloyl glucoside 49.23 8.14 42.78 0.00 -17.74 32.42 4.76 35.88 0.00 -21.68
Loliolide 29.61 0.10 23.41 0.00 -2.68 31.02 3.34 22.10 0.00 -2.71
Luteolin-7-glucoside 47.87 10.04 42.46 0.00 -20.56 43.85 2.46 42.08 0.00 -16.48
Apigenin-7- glucocronide 45.63 8.34 39.19 0.00 -16.59 43.35 8.74 37.80 0.00 -17.36
D-mannitol 32.55 9.88 23.13 0.00 -9.13 30.21 8.15 20.48 0.00 -6.11
L-asperatic acid 33.35 17.74 17.07 0.00 -7.86 28.29 14.01 16.69 0.00 -8.66
Luteolin 53.77 11.23 37.44 0.00 -8.94 45.35 7.81 41.67 0.00 -19.77
Penicillin G - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 46.48 2.62 35.14 0.00 -4.46















Figure 2 Interaction and superimposed structure of compound of luteolin and ciprofloxacin with DNA gyrase.
Emran et al. DARU Journal of Pharmaceutical Sciences  (2015) 23:26 Page 7 of 8be used as substitutes for drugs. Research work on me-
dicinal plants and exchange of obtained information
will go a long way in scientific exploration of medicinal
plants for the benefit of mankind. This will ultimately
decrease our dependence on synthetic drugs [26]. Plant
synthesizes natural products as its chemical weapon
that arrests the growth of environmental microbes [27]
and some plants inhibit the growth of potential human
pathogens too. In the current study, in vitro MIC of
B. monnieri leaf parts, prescribed in indigenous system
of medicine, that are available in the local market or
growing in Bangladesh and India were evaluated
against local clinical bacterial isolate of S. aureus. De-
termination of MIC of this plant is important to find
out the best plant that eradicates infectious agents
(Table 2). Clinicians also select the antibiotic on the
basis of their MIC value to treat infectious diseases.
Plant extracts having MIC below 8000 μg/ml have been
reported as therapeutically effective [28]. Our results
for B. monnieri implicated a significant MIC valueFigure 3 Interaction and superimposed structure of compound of luteolin(below or equal to 75 μg/ml) in this study. This sig-
nificance suggests that we have identified antimicrobial
activity of plant that is effective for arresting the growth of
S. aureus causing hospital-,-acquired- and opportunistic-
infections.Conclusions
B. monnieri extract and its compound luteolin have
a significant antimicrobial activity against S. aureus.
Molecular binding interaction of in silico data demon-
strated that luteolin has more specificity towards the
DNA gyrase binding site and could be a potent anti-
microbial compound. However several scientific reports
manifested that lead-drug discovery projects on the basis
of binding efficiency indices would afford bioactive com-
pounds with better pharmacokinetic outcomes. Hence,
isolated bioactive compounds should be employed for
establishing more rational structure activity relationships
in the era of antimicrobial drug development.and penicillin G with penicillin binding protein.
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